Literature DB >> 18489900

Cholesterol domains in cationic lipid/DNA complexes improve transfection.

Long Xu1, Thomas J Anchordoquy.   

Abstract

The interaction between the cationic lipid DOTAP and cholesterol is examined in high cholesterol formulations by differential scanning calorimetry (DSC). Preparation of liposomes above 66 mol% cholesterol results in formulations that exhibit a calorimetric transition for anhydrous cholesterol at 38-40 degrees C. The enthalpy of this transition progressively increases at higher cholesterol contents, and is not detected below 66 mol% cholesterol. Furthermore, the enthalpy changes indicate that the composition of the non-domain forming portion containing DOTAP saturated with cholesterol is relatively constant above 66 mol% cholesterol. Greater transfection efficiency in the presence of 50% serum is observed at the formulations with high cholesterol contents where anhydrous cholesterol domains are detected by DSC. Although formulations possessing higher cholesterol exhibited a greater resistance to serum-induced aggregation, maintenance of small particle size does not appear to be responsible for the enhanced transfection efficiency. Additional studies quantifying albumin binding suggest that cholesterol domains in the lipid/DNA complex do not bind protein, and this may enable these moieties to enhance transfection by facilitating membrane fusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18489900     DOI: 10.1016/j.bbamem.2008.04.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

1.  Optimizing cationic and neutral lipids for efficient gene delivery at high serum content.

Authors:  Chia-Ling Chan; Kai K Ewert; Ramsey N Majzoub; Yeu-Kuang Hwu; Keng S Liang; Cecília Leal; Cyrus R Safinya
Journal:  J Gene Med       Date:  2014 Mar-Apr       Impact factor: 4.565

2.  The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro.

Authors:  Long Xu; Michael F Wempe; Thomas J Anchordoquy
Journal:  Ther Deliv       Date:  2011-04

3.  Ligands located within a cholesterol domain enhance gene delivery to the target tissue.

Authors:  Long Xu; Jamie Betker; Hao Yin; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2012-03-09       Impact factor: 9.776

4.  Silica nanoparticle supported lipid bilayers for gene delivery.

Authors:  Juewen Liu; Alison Stace-Naughton; C Jeffrey Brinker
Journal:  Chem Commun (Camb)       Date:  2009-07-28       Impact factor: 6.222

5.  A novel method for conjugating the terminal amine of peptide ligands to cholesterol: synthesis iRGD-cholesterol.

Authors:  Matthew G Fete; Jamie L Betker; Richard K Shoemaker; Thomas J Anchordoquy
Journal:  Ther Deliv       Date:  2019-01

6.  Assessing the effect of a nude mouse model on nanoparticle-mediated gene delivery.

Authors:  Jamie L Betker; Thomas J Anchordoquy
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

Review 7.  Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

Authors:  Long Xu; Thomas Anchordoquy
Journal:  J Pharm Sci       Date:  2011-01       Impact factor: 3.534

8.  The antitumor efficacy of docetaxel is enhanced by encapsulation in novel amphiphilic polymer cholesterol-coupled tocopheryl polyethylene glycol 1000 succinate micelles.

Authors:  Qingjing Tian; Jia Shi; Xiaoyun Zhao; Donghua Di; Yihui Deng; Yanzhi Song
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

9.  Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.

Authors:  Jamie L Betker; Dallas Jones; Christine R Childs; Karen M Helm; Kristina Terrell; Maria A Nagel; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2018-07-17       Impact factor: 9.776

10.  Questioning the Use of PEGylation for Drug Delivery.

Authors:  Johan J F Verhoef; Thomas J Anchordoquy
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.